Patent-pending antibody allows easier tracking of treatment effectiveness
Scientists from NTU Singapore, the world’s No. 1 young university, have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia.
Proven effective in lab tests, the antibody is now being made suitable for use in humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.
The patent-pending antibody has generated much interest globally. Two biotech multi-national corporations, Abcam based in the United Kingdom and Adipogen International based in the United States, have won the rights to license the antibody. The two multinational companies will produce the antibody for sale to global organisations doing research in vaccine and drug development.
The breakthrough finding was published in the latest issue of the prestigious international peer-reviewed journal Cell Reports.
Influenza epidemics, such as the deadly 1918 Spanish Flu which killed over 50 million people or the severe acute respiratory syndrome (SARS) outbreak in 2002, are of big concern to governments and the general populace worldwide.
The World Health Organisation estimated that influenza results in about 3 to 5 million cases of severe illness worldwide each year, with about 250,000 to 500,000 deaths annually.
Pneumonia is the leading cause of death in children worldwide accounting for 15 per cent of all deaths for children under 5 years old, and is among the top 10 leading causes of death in the United States.
This new antibody was developed by NTU Singapore’s Associate Professor Andrew Tan, who led an interdisciplinary team of scientists from Singapore.
“While it will take up to eight years to develop the antibody into a useable treatment for human patients, we are currently developing a diagnostic kit which should be commercialised in about three years,” said Assoc Prof Tan.
“The kit will help doctors diagnose the severity of pneumonia and the efficacy of the prescribed treatment. This is done by detecting the concentration of a particular protein called ANGPTL4, which is present in samples taken from patients suffering from upper respiratory tract infections.”
The Latest on: Pandemics
[google_news title=”” keyword=”Pandemics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pandemics
- UT professor leading a team of scientists from across the globe to help plan for future pandemicson September 28, 2023 at 11:03 am
"Models and data are among the most critical weapons in our arsenal," says Lauren Ancel Meyers, director of the Center for Pandemic Decision Science at UT.
- UKHSA secures UK-based vaccine deal for future influenza pandemicson September 28, 2023 at 5:20 am
The UK Health Security Agency (UKHSA) has announced a new vaccine deal to produce millions of life-saving vaccines in the UK in preparation for potential future influenza pandemics. The first UK-based ...
- What Is Pandemic Accord? How It Can Help Us Prepare Against Future Pandemicson September 28, 2023 at 3:24 am
The Pandemic Accord, called the pandemic treaty, helps us prevent and prepare for future global health threats. Maurice Remy from Universities Allied for Essential Medicines said that young people are ...
- Two pandemics more than 100 years apart – comparison reveals best strategies for the futureon September 27, 2023 at 5:00 pm
A vigorous elimination strategy should be considered and equity needs to be top of the list of priorities for future severe pandemics, researchers say.
- Meet the people who helped us understand pandemicson September 27, 2023 at 2:35 am
"Foreign Bodies: Pandemics, Vaccines, and the Health of Nations" By Simon Schama, published by Ecco, 480 pages, $32.99 No one would accuse Simon Schama of writing a blasé book, even when he ventures ...
- More pandemics ahead? Wuhan 'batwoman' says 20 coronaviruses have 'high risk' of human outbreakson September 25, 2023 at 10:19 pm
Scientists predict more coronavirus pandemics as world recovers from COVID-19. 20 coronaviruses likely to infect humans.
- Emerging pandemics and the role of batson September 25, 2023 at 2:21 pm
Many viral infections that plague humans originate from bats, yet intriguingly bats suffer no ill effects from the myriad of viruses that inhabit their bodies, a phenomenon scientists are researching ...
- 'Foreign Bodies' traces the history of pandemics and vaccine hesitancyon September 24, 2023 at 9:09 pm
Pandemics, Vaccines, and the Health of Nations, recounts the pain and panic caused by smallpox, cholera and the Bubonic plague over the past two centuries. But he also examines how vaccines were ...
- Review: A historical look at the people who helped us understand pandemicson September 23, 2023 at 9:00 am
Aart historian and Europhile turns his colossal erudition to pandemics and the women and men who transformed our understanding of them.
- Sustainable funding required to respond to pandemics as one global community: Ong Ye Kungon September 22, 2023 at 9:08 am
To ensure the global commons work well, funding is required in the three key areas. Read more at straitstimes.com.
via Bing News